Skip to Content

Chemical Works of Gedeon Richter PLC RICHTER

Morningstar Rating
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

RICHTER is trading within a range we consider fairly valued.
Price
HUF 8,906.65
Fair Value
HUF 2,619.68
Uncertainty
High
1-Star Price
HUF 63,553.80
5-Star Price
HUF 8,383.43
Economic Moat
Wgqvcp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if RICHTER is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
8.51
Price/Sales
3.99
Dividend Yield
4.39%
Dividend Yield (Forward)
4.39%
Total Yield
5.53%

Company Profile

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
12,180

Valuation

Metric
RICHTER
Price/Earnings (Normalized)
8.51
Price/Book Value
1.52
Price/Sales
3.99
Price/Cash Flow
14.43
Price/Earnings
RICHTER

Financial Strength

Metric
RICHTER
Quick Ratio
2.04
Current Ratio
3.49
Interest Coverage
8.74
Quick Ratio
RICHTER

Profitability

Metric
RICHTER
Return on Assets (Normalized)
10.17%
Return on Equity (Normalized)
12.76%
Return on Invested Capital (Normalized)
13.21%
Return on Assets
RICHTER

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ADdcp$83.5 Bil
MKKGY
Merck KGaA ADRRmyncq$67.6 Bil
HLN
Haleon PLC ADRXfsc$37.5 Bil
VTRS
Viatris IncMnt$11.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRQmnl$11.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRHqx$10.5 Bil
CTLT
Catalent IncKwbgprl$6.8 Bil
PRGO
Perrigo Co PLCYzj$4.1 Bil
CURLF
Curaleaf Holdings IncHjbq$3.1 Bil
PBH
Prestige Consumer Healthcare IncXrtyfjc$3.0 Bil